© 2021 by the authors.Among the described druggable vulnerabilities, acting on the DNA repair mechanism has gained momentum, with the approval of PARP inhibitors in several indications, including breast cancer. However, beyond the mere presence of BRCA1/BRCA2 mutations, the identification of additional biomarkers that would help to select tumors with an extreme dependence on DNA repair machinery would help to stratify therapeutic decisions. Gene set enrichment analyses (GSEA) using public datasets evaluating expression values between normal breast tissue and breast cancer identified a set of upregulated genes. Genes included in different pathways, such as ATM/ATR, BARD1, and Fanconi Anemia, which are involved in the DNA damage response, wer...
Breast cancer is a heterogeneous disease with known expression-defined tumor subtypes. DNA copy numb...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
[Background]: Control of DNA damage is frequently deregulated in solid tumors. Upregulation of genes...
SummaryThis study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pat...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
It has, for many years, been acknowledged that “breast cancer” is an umbrella term for many genetica...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
The DNA damage response (DDR) involves the activation of numerous cellular activities that repair DN...
The application of high throughput techniques to profile DNA, RNA and protein in breast cancer sampl...
Breast cancer is one of the most commonly diagnosed cancers in women. While there are several effect...
© 2019 Na LiThe genetic causes of the majority of hereditary breast cancer families remain unresolve...
Breast cancer is a heterogeneous disease with known expression-defined tumor subtypes. DNA copy numb...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
[Background]: Control of DNA damage is frequently deregulated in solid tumors. Upregulation of genes...
SummaryThis study explores the roles of genome copy number abnormalities (CNAs) in breast cancer pat...
Impaired DNA repair drives mutagenicity, which increases neoantigen load and immunogenicity. We inve...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
It has, for many years, been acknowledged that “breast cancer” is an umbrella term for many genetica...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
Breast cancers can be divided into subtypes with important implications for prognosis and treatment....
The DNA damage response (DDR) involves the activation of numerous cellular activities that repair DN...
The application of high throughput techniques to profile DNA, RNA and protein in breast cancer sampl...
Breast cancer is one of the most commonly diagnosed cancers in women. While there are several effect...
© 2019 Na LiThe genetic causes of the majority of hereditary breast cancer families remain unresolve...
Breast cancer is a heterogeneous disease with known expression-defined tumor subtypes. DNA copy numb...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Abstract Germline-somatic mutation interactions are universal and associated with tumorigenesis, but...